Koyamangalath Krishnan, MD / Patient Care | Quillen ETSU Physicians | Regional Cancer Center
Professor, Chair of Excellence, Fellowship Program Director | Division of Hematology/Oncology
Academic Office: VA Building #119, Room 139
Contact: 423.439.6362 | email@example.com
Koyamangalath Krishnan, M.D. holds the Dishner Chair of Excellence in Medicine at East Tennessee State University’s Quillen College of Medicine in Johnson City. He is Chief of the Division of Hematology/Oncology in the Department of Internal Medicine, where he also directs its Medical Oncology Fellowship Program.
After earning his medical degree in his native India, Dr. Krishnan continued his studies at the Royal College of Physicians of the United Kingdom in London. He then received postdoctoral training in Hematology at the Royal Postgraduate Medical School and the University of London’s Hammersmith Hospital. Prior to moving to the U.S., Dr. Krishnan spent five years with the U.K.’s National Health Service, serving in several capacities while receiving additional training in Internal Medicine and Hematology.
Dr. Krishnan completed his residency in Internal Medicine at East Tennessee State University and his fellowship in Hematology/Oncology at the University of Michigan’s School of Medicine. He spent two years on the faculty of the MD Anderson Cancer Center before being tapped to head the Division of Hematology/Oncology at East Tennessee State University.
An active researcher, Dr. Krishnan has authored several book chapters and more than 50 articles in peer-reviewed journals. He has served as research mentor to medical students as well as residents and fellows, and as a member of both Ph.D. and Master’s-level advisory committees. He is Chief Editor of Medscape’s Hematology Section and has served as a reviewer for several print journals, including PLoS One, Toxicological Sciences, and the American Journal of Hospice and Palliative Medicine.
Dr. Krishnan is board-certified in Medical Oncology and is a member of the American Society of Clinical Oncology and the American Association of Cancer Research. He also is a fellow of the American College of Physicians and the Royal College of Physicians of the United Kingdom.